Related by context. Frequent words. (Click for all words.) 70 HBeAg 69 refractory chronic lymphocytic 67 hepatitis C HCV 66 coinfection 66 virus HCV infection 65 seronegative 64 hepatitis B HBV 64 HBeAg positive 64 Chronic Hepatitis C 64 recurrent glioblastoma multiforme 64 Tyzeka 64 hypophosphatemia 64 coinfected 63 latent tuberculosis infection 63 TTR amyloidosis 63 hepatocellular cancer 63 chronic HBV infection 63 Chronic Hepatitis B 62 fibrosis IPF 62 Epratuzumab 62 SSc 62 candidemia 62 HBsAg 62 leukemia ALL 62 chronic hepatitis B. 61 J Am Coll 61 cytomegalovirus CMV 61 Human papillomavirus 61 CCR5 tropic HIV 61 forodesine 61 2 methoxyestradiol 61 posaconazole 61 Initiate Phase 61 pegylated interferon alfa 2a 61 estrogen receptor ER 60 HIV uninfected 60 receiving VELCADE 60 gastrointestinal stromal tumors GIST 60 Telbivudine 60 breast pancreatic 60 multiple myeloma MM 60 Myelofibrosis 60 HCV genotype 60 Cytomegalovirus 60 Idiopathic Pulmonary Fibrosis 60 Hemorrhagic 60 methicillin resistant S. aureus 60 Respiratory Syncytial Virus RSV 60 Previously Treated 60 HCV genotypes 60 mRCC 60 Clevudine 59 plus OBT 59 Hepatitis C HCV 59 cutaneous T 59 metastatic castration resistant 59 Darinaparsin 59 cell acute lymphoblastic 59 peginterferon alfa 59 lupus erythematosus 59 alanine aminotransferase ALT 59 Asymptomatic 59 Epidermal Growth Factor Receptor 59 oral candidiasis 59 hepatitis B infection 59 CCR5 antagonist 59 FLT3 59 VEGFR2 inhibitor 59 gets USFDA nod 59 acquired immunodeficiency syndrome 59 murine model 59 R sorafenib tablets 59 Herpes Simplex Virus 59 Racivir 59 Diabetic Neuropathy 59 Hepatitis C Virus HCV 59 Hepatitis C virus HCV 59 alanine aminotransferase 59 transcriptase inhibitors 59 HIV human immunodeficiency 59 pemphigus vulgaris 59 polymerase inhibitor 59 Meets Primary Endpoint 59 HCV genotype 1 59 elvucitabine 59 Panzem R 59 colorectal carcinoma 59 leukemia CLL 59 nucleoside analogue 59 Streptococcus pyogenes 59 FeLV 59 Natalizumab 58 voriconazole 58 Daclizumab 58 Epivir 58 TREATMENT OF 58 ethambutol 58 Chronic Myeloid Leukemia 58 Initiates Phase II 58 histologically confirmed 58 Recombinant Human